Mandelic Acid

Mandelic Acid

SCHEMBL8937190

CC(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)c1ccccc1.O=C(O)CC(O)C(=O)O.O=C(O)CO

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Mandelic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.50
MAPK1 P28482 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.42
FFAR1 O14842 1/20 0.38
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
HPGD P15428 2/20 0.36
GABBR2 O75899 1/20 0.36
GABBR1 Q9UBS5 1/20 0.36
HIF1A Q16665 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
LTA4H P09960 2/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mandelic Acid SCHEMBL3711577 0.85 LMNA (0.69) LMNAMAPK1SMN1; SMN2FFAR1CYP2D6
Mandelic Acid SCHEMBL3456058 0.81 LMNA (0.62) LMNAMAPK1SMN1; SMN2CYP2D6CYP2C19
Cadaverine Tartrate SCHEMBL8157715 0.79 SMN1; SMN2 (0.38) SMN1; SMN2FFAR1TSHRMEN1KMT2A
Cadaverine Tartrate SCHEMBL8157703 0.79 SMN1; SMN2 (0.38) SMN1; SMN2FFAR1TSHRMEN1KMT2A
Mandelic Acid SCHEMBL8630179 0.78 LMNA (0.82) LMNAMAPK1TP53CYP1A2CYP2D6
Cadaverine Tartrate SCHEMBL18895372 0.78 SMN1; SMN2 (0.68) SMN1; SMN2TP53TSHR
Mandelic Acid SCHEMBL531056 0.76 LMNA (0.86) LMNAMAPK1CYP2D6TSHRHPGD
Malic Acid SCHEMBL339198 0.76 TAAR1 (0.63) LMNAMAPK1SMN1; SMN2FFAR1CYP2C19
Malic Acid SCHEMBL6787423 0.76 TAAR1 (0.63) LMNAMAPK1SMN1; SMN2FFAR1CYP2C19
Malic Acid SCHEMBL7191878 0.76 TAAR1 (0.63) LMNAMAPK1SMN1; SMN2FFAR1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0668808-A4 NO-CLEAN SOLDERING FLUX AND METHOD USING THE SAME. FRY METALS INC (US) 1996-04-24 EP disclosed
EP-0668808-A1 NO-CLEAN SOLDERING FLUX AND METHOD USING THE SAME FRY'S METALS, INC. (US) 1995-08-30 EP disclosed
WO-1994011148-A1 NO-CLEAN SOLDERING FLUX AND METHOD USING THE SAME FRY'S METALS, INC. (US) 1994-05-26 WO disclosed